Education
About Us
Working with TipRanks
Follow Us
Deltagen Inc (DGEN)
OTHER OTC:DGEN
DGEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.02
Previous CloseN/A
Volume300.00
Average Volume (3M)10.00K
Market Cap
$39.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta21.59
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding38,594,000
10 Day Avg. Volume10,000
30 Day Avg. Volume10,000
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DGEN FAQ
What was Deltagen Inc’s price range in the past 12 months?
Deltagen Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Deltagen Inc’s market cap?
Deltagen Inc’s market cap is $39.00.
When is Deltagen Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Deltagen Inc’s earnings last quarter?
Currently, no data Available
Is Deltagen Inc overvalued?
According to Wall Street analysts Deltagen Inc’s price is currently Overvalued.
Does Deltagen Inc pay dividends?
Deltagen Inc does not currently pay dividends.
What is Deltagen Inc’s EPS estimate?
Deltagen Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Deltagen Inc have?
Deltagen Inc has 38,594,000 shares outstanding.
What happened to Deltagen Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Deltagen Inc?
Currently, no hedge funds are holding shares in DGEN
Company Description
Deltagen Inc
Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.
Technical Analysis
Harvard Bioscience
―
Predictive Oncology
―
GlucoTrack
―
Femasys
―
Meihua International Medical Technologies Co., Ltd.
―